MARC Record from marc_columbia

LEADER: 05013fam a2200385 a 4500
001 4047239
005 20221027024218.0
008 940210t19941994enka b 001 0 eng c
010 $a 94006104
020 $a0471940585
035 $a(OCoLC)29912261
035 $a(OCoLC)ocm29912261
035 $9AKL9372HS
035 $a(NNC)4047239
035 $a4047239
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB
050 00 $aRM302.5$b.P53 1994
060 10 $aQZ 42 P536 1994
082 00 $a615/.704$220
245 00 $aPharmacoepidemiology /$cedited by Brian L. Strom.
250 $a2nd ed.
260 $aChichester ;$aNew York :$bJ. Wiley,$c[1994], ©1994.
300 $axviii, 741 pages :$billustrations ;$c26 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 0 $a1. What is Pharmacoepidemiology? / Brian L. Strom -- 2. Study Designs Available for Pharmacoepidemiology Studies / Brian L. Strom -- 3. Sample Size Considerations for Pharmacoepidemiology Studies / Brian L. Strom -- 4. Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiology Studies / David A. Henry, Anthony J. Smith and Sean Hennessy -- 5. When Should One Perform Pharmacoepidemiology Studies? / Brian L. Strom -- 6. A Public Health Perspective from Academia / Paul D. Stolley -- 7. A View from Industry / Gretchen S. Dieck, Dale B. Glasser and Roger M. Sachs -- 8. A View from a Regulatory Agency / Janet B. Arrowsmith-Lowe and Charles Anello -- 9. Pharmacoepidemiology: A View from the US Courtroom / Sidney H. Willig and James R. Ruger -- 10. The Spontaneous Reporting System in the United States / Carlene Baum, Sandra L. Kweder and Charles Anello -- 11. Spontaneous Reporting Systems Outside the United States / Bengt-Erik Wiholm, Sten Olsson, Nicolas Moore and Susan Wood.
505 8 $a12. Intensive Hospital-based Cohort Studies / David H. Lawson and Keith Beard -- 13. Group Health Cooperative of Puget Sound / Kathleen W. Saunders, Andy Stergachis and Michael Von Korff -- 14. Kaiser Permanente Medical Care Program: Northern California and Other Regions / Gary D. Friedman -- 15. Medicaid Databases / Jeffrey L. Carson and Brian L. Strom -- 16. Health Databases in Saskatchewan / Linda M. Strand and Winanne Downey -- 17. Automated Record Linkage and Other Approaches to Pharmacoepidemiology in The Netherlands / Hubert G. Leufkens and John Urquhart -- 18. The Tayside Medicines Monitoring Unit (MEMO) / Thomas M. MacDonald and Denis G. McDevitt -- 19. Inpatient Databases / Judith K. Jones, John H. Kurata and Linda J. Miwa -- 20. Harvard Community Health Plan / Richard Platt -- 21. Clinical Pharmacy Drug Surveillance Network / Thaddeus H. Grasela, Jr. -- 22. Case-Control Surveillance / Samuel Shapiro -- 23. Other Approaches to Pharmacoepidemiology Studies / Brian L. Strom.
505 8 $a24. How Should One Perform Pharmacoepidemiology Studies? Choosing Among the Available Alternatives / Brian L. Strom -- 25. Premarketing Applications of Pharmacoepidemiology / Harry A. Guess -- 26. Determining Causation from Case Reports / Judith K. Jones -- 27. Studies of Drug Utilization / David Lee and Ulf Bergman -- 28. Evaluating and Improving Physician Prescribing / Stephen B. Soumerai and Helene L. Lipton -- 29. The Role of Therapeutic Drug Monitoring in Pharmacoepidemiology / Thaddeus H. Grasela, Jr. -- 30. Screening for Unknown Effects of Newly Marketed Drugs / Jeffrey L. Carson, Brian L. Strom and Gregory Maislin -- 31. The Use of Pharmacoepidemiology to Study Beneficial Drug Effects / Brian L. Strom and Kenneth L. Melmon -- 32. Pharmacoeconomics: Economic Evaluation of Pharmaceuticals / John M. Eisenberg, Kevin A. Schulman, Henry Glick and Harris Koffer -- 33. Using Quality-of-Life Measurements in Pharmacoepidemiology Research / Roman Jaeschke and Gordon H. Guyatt.
505 8 $a34. N-of-1 Randomized Clinical Trials in Pharmacoepidemiology / Gordon H. Guyatt, Roman Jaeschke and Robin Roberts -- 35. The Use of Meta-analysis in Pharmacoepidemiology / Jesse A. Berlin -- 36. Validity of Pharmacoepidemiology Drug and Diagnosis Data / Suzanne L. West and Brian L. Strom -- 37. Special Methodological Issues in Pharmacoepidemiology Studies of Vaccine Safety / Robert T. Chen -- 38. Special Considerations in Studies of Drug-induced Birth Defects / Allen A. Mitchell -- 39. Bias and Confounding in Pharmacoepidemiology / J. P. Collet, J. F. Boivin and W. O. Spitzer -- 40. Novel Approaches to Pharmacoepidemiology Study Design and Statistical Analysis / Samy Suissa -- 41. The Future of Pharmacoepidemiology / Brian L. Strom.
650 0 $aPharmacoepidemiology.$0http://id.loc.gov/authorities/subjects/sh89004031
650 2 $aDrug-Related Side Effects and Adverse Reactions.$0https://id.nlm.nih.gov/mesh/D064420
650 2 $aEpidemiologic Methods.$0https://id.nlm.nih.gov/mesh/D004812
700 1 $aStrom, Brian L.$0http://id.loc.gov/authorities/names/n88088423
852 00 $boff,hsl$hRM302.5$i.P53 1994